NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Innovision IPO Update

IPO Details

  • Listing Period: 10 March 2026 - 13 March 2026
  • Price Band: ₹521 - ₹548 per share
  • Fund Raising: ₹323 crore (₹68 crore through Offer for Sale and ₹255 crore through fresh shares)
  • Lot Size: 27 shares

Grey Market Premium

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

  • Grey Market Premium (GMP): ₹71
  • Listing Gain: Approximately 13% against the upper price band of ₹548 apiece

Subscription Status

  • Public Issue Subscription: 0.30 times
  • Retail Portion Subscription: 0.27 times
  • NII Segment Subscription: 0.35 times
  • QIB Portion Subscription: 0.95 times

Allotment and Listing Dates

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

  • Most Likely Allotment Date: 16 March 2026 (due to Saturday on 14 March 2026)
  • Most Likely Listing Date: 18 March 2026 (Wednesday next week)

Company Performance

  • Net Revenue: ₹893.1 crore in FY25 (75% YoY growth from ₹510.3 crore in FY24)
  • EBITDA: ₹48.9 crore in FY25 (174% YoY increase from ₹17.9 crore in FY24)
  • Profit: ₹30.0 crore in FY25 (189% YoY growth from ₹10.4 crore in FY24)
  • EBITDA Margin: 5.5% in FY25 (improved from 3.5% in FY24)
  • Profit Margin: 3.4% in FY25 (expanded from 2.0% in FY24)

Investor Takeaway

Investors have one day left to apply for the Innovision IPO, with a potential listing gain of around 13%.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.